Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) announced that the Food and Drug Administration (FDA) has granted tentative approval to the Company’s ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE